Cargando…
T Cell Activation Machinery: Form and Function in Natural and Engineered Immune Receptors
The impressive success of chimeric antigen receptor (CAR)-T cell therapies in treating advanced B-cell malignancies has spurred a frenzy of activity aimed at developing CAR-T therapies for other cancers, particularly solid tumors, and optimizing engineered T cells for maximum clinical benefit in man...
Autores principales: | Chandler, Nicholas J., Call, Melissa J., Call, Matthew E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7582382/ https://www.ncbi.nlm.nih.gov/pubmed/33050044 http://dx.doi.org/10.3390/ijms21197424 |
Ejemplares similares
-
De novo-designed transmembrane domains tune engineered receptor functions
por: Elazar, Assaf, et al.
Publicado: (2022) -
T cell and B cell antigen receptors share a conserved core transmembrane structure
por: Ramesh, Samyuktha, et al.
Publicado: (2022) -
The Influence of Chimeric Antigen Receptor Structural Domains on Clinical Outcomes and Associated Toxicities
por: Davey, Ashleigh S., et al.
Publicado: (2020) -
Lysosomal Machinery Drives Extracellular Acidification to Direct Non-apoptotic Cell Death
por: Mondragon, Albert A., et al.
Publicado: (2019) -
Strategies for in vitro engineering of the translation machinery
por: Hammerling, Michael J, et al.
Publicado: (2020)